Literature DB >> 15677808

The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.

Elena Volpi1, Steven A Lieberman, Dennis M Ferrer, Charles R Gilkison, Blake B Rasmussen, Manubai Nagamani, Randall J Urban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15677808      PMCID： PMC3174777          DOI： 10.2337/diacare.28.2.429

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  23 in total

1.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

Authors:  S Bhasin; T W Storer; N Berman; C Callegari; B Clevenger; J Phillips; T J Bunnell; R Tricker; A Shirazi; R Casaburi
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

2.  Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome.

Authors:  A Dunaif; G Green; W Futterweit; A Dobrjansky
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

3.  Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding.

Authors:  E D Schriock; C K Buffington; G D Hubert; B R Kurtz; A E Kitabchi; J E Buster; J R Givens
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

4.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women.

Authors:  D J Evans; R G Hoffmann; R K Kalkhoff; A H Kissebah
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

5.  Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.

Authors:  J C Seidell; P Björntorp; L Sjöström; H Kvist; R Sannerstedt
Journal:  Metabolism       Date:  1990-09       Impact factor: 8.694

6.  Increased expression of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage and P450 17alpha-hydroxylase enzymes in ovarian hyperthecosis.

Authors:  M Nagamani; R J Urban
Journal:  Fertil Steril       Date:  1999-02       Impact factor: 7.329

7.  Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women.

Authors:  A N Peiris; R A Mueller; M F Struve; G A Smith; A H Kissebah
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

8.  Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism.

Authors:  H Hauner; H H Ditschuneit; S B Pal; R Moncayo; E F Pfeiffer
Journal:  Metabolism       Date:  1988-03       Impact factor: 8.694

9.  Serum testosterone concentrations in the evaluation of androgen-producing tumors.

Authors:  C I Friedman; G E Schmidt; M H Kim; J Powell
Journal:  Am J Obstet Gynecol       Date:  1985-09-01       Impact factor: 8.661

Review 10.  Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394
View more
  2 in total

1.  Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.

Authors:  K Co Reddy; S B Yadav
Journal:  J Postgrad Med       Date:  2021 Apr-Jun       Impact factor: 1.476

2.  Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance.

Authors:  Dessy Amelia; Budi Santoso; Bambang Purwanto; Muhammad Miftahussurur; Hermanto Tri Joewono
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2018-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.